However, in the studies mentioned above, the criteria of defining HER2 status was adopted, which, used in breast cancer and HER2 IHC staining 2+ together with staining 3+, were classified as positive [8,9,10,11,12]. This evidence concerns the gene ERBB2 and breast carcinoma.